LT variations | R^{2} | B | 95% CI |
p Linear regression |
---|---|---|---|---|
Days of follow-up (with PN) | ||||
GGT | 0.041 | 0.074 | 1.045–2.117 | 0.006 |
AP | 0.372 | 0.135 | 0.109–0.161 | 0.000 |
ALT | 0.001 | 0.004 | −0.015-0.024 | 0.807 |
TB | 0.018 | 0.101 | −0.010-0.213 | 0.075 |
CRP at the end of study | ||||
GGT | 0.009 | 0.002 | −0.001–0.005 | 0.217 |
AP | 0.043 | 0.003 | 0.001–0.005 | 0.005 |
ALT | 0.000 | 0.000 | −0.001-0.001 | 0.847 |
TB | 0.002 | 0.002 | −0.009-0.005 | 0.581 |
Leukocytes at the end of study | ||||
GGT | 0.011 | 0.053 | −0.020-0.126 | 0.157 |
AP | 0.011 | 0.611 | −0.013-0.075 | 0.168 |
ALT | 0.006 | 0.014 | −0.013-0.040 | 0.313 |
TB | 0.026 | 0.166 | 0.014–0.318 | 0.032 |
Cancer | ||||
LT variations |
No (n = 60) Mean ± SD |
Yes (n = 121) Mean ± SD |
p student t-test | |
GGT | 1.48 ± 1.49 | 2.48 ± 2.76 | 0.002 | |
AP | 0.77 ± 0.97 | 1.02 ± 1.68 | 0.283 | |
ALT | 0.38 ± 1.42 | 0.18 ± 0.41 | 0.293 | |
TB | −0.89 ± 6.69 | 6.69 ± 4.14 | 0.815 | |
Infection | ||||
LT variations |
No (n = 114) Mean ± SD |
Beginning PN (n = 17) Mean ± SD |
During PN (n = 50) Mean ± SD |
p ANOVA |
GGT | 1.96 ± 2.67 | 1.76 ± 1.39 | 2.69 ± 2.14 | 0.173 |
AP | 0.76 ± 0.93^{b} | 0.71 ± 0.62 | 1.42 ± 2.36^{b} | 0.025 |
ALT | 0.16 ± 0.40 | 0.31 ± 0.68 | 0.42 ± 1.52 | 0.223 |
TB | −1.54 ± 4.18 | −0.58 ± 3.15 | 0.18 ± 7.06 | 0.184 |
Surgery | ||||
LT variations |
No (n = 37) Mean ± SD |
Beginning PN (n = 132) Mean ± SD |
During PN (n = 12) Mean ± SD |
P ANOVA |
GGT | 1.01 ± 1.54^{a,b} | 2.38 ± 2.56^{a} | 3.06 ± 2.60^{b} | 0.004 |
AP | 0.48 ± 0.99^{b} | 0.94 ± 0.99^{c} | 2.34 ± 4.27^{b,c} | 0.001 |
ALT | 0.25 ± 0.44^{b} | 0.25 ± 1.00 | 0.22 ± 0.48 | 0.993 |
TB | −2.26 ± 4.98^{b} | −0.95 ± 5.19 | 1.93 ± 3.06^{b} | 0.044 |